Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe in Chronic Hepatitis C
NCT00475176Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- May 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of S-adenosylmethionine in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Improvement in Viral Kinetics During the First 2 Weeks of Therapy. Started May 2007; status: completed.
02
Drugs
S-adenosylmethionine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00475176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475176.